Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
deals
7
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
roche
san francisco blog main
boston
cancer
clinical trials
crispr
gene therapy
national
new york blog main
new york top stories
novartis
pfizer
san diego blog main
san diego top stories
san francisco top stories
alexion pharmaceuticals
alzheimer's disease
biogen
boulder/denver blog main
boulder/denver top stories
car-t
celgene
detroit blog main
detroit top stories
editas medicine
europe blog main
gene editing
hemophilia
indiana blog main
indiana top stories
ipo
medicaid
medicare
What
gene
7
×
therapy
bio
drug
medicine
medicines
research
roche
roundup
therapeutics
treatment
abbvie
access
advanced
alliance
alzheimer’s
approval
becker
betting
billion
billions
biopharma
biotech
capacity
car
caught
causing
cell
companies
consolidation
crispr
crude
cutting
deal
despite
dicerna
different
disease
dollars
duchenne
Language
unset
Current search:
biotech
×
deals
×
gene
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More